Pharmstandard International S.A. Q3 2018 significant ownership

Add to watchlist

Pharmstandard International S.A. is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

Pharmstandard International S.A. Q3 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Protagonist Therapeutics, IncFebruary 21, 2018982,2704.8%
ARGOS THERAPEUTICS INCJune 26, 201718,362,88339.9%
PROTEON THERAPEUTICS INCFebruary 12, 20151,165,3447.1%

Compare quarters

Export Pharmstandard International S.A.'s holdings

CSVXLS